Arnold R Gammaitoni (Arnold Gammaitoni)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Venues

Epilepsia

Epilepsia open

Zogenix Inc

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Zogenix Inc Nov 03 2013

United States

VP, Medical & Scientific Affairs :: Medical

Publications

Joseph Sullivan, Lieven Lagae, Judith Helen Cross, Orrin Devinsky, Renzo Guerrini, Kelly G Knupp, Linda Laux, Marina Nikanorova, Tilman Polster, Dinesh Talwar, Berten Ceulemans, Rima Nabbout, Gail M Farfel, Bradley S Galer, Arnold R Gammaitoni, Michael Lock, Anupam Agarwal, Ingrid Eileen Scheffer, null null
Fenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo-controlled clinical trial. Epilepsia (2023)
John Cha, Gregory Filatov, Steven J Smith, Arnold R Gammaitoni, Amélie Lothe, Thadd Reeder
Fenfluramine increases survival and reduces markers of neurodegeneration in a mouse model of Dravet syndrome. Epilepsia open (2023)
Kelly G Knupp, Ingrid Eileen Scheffer, Berten Ceulemans, Joseph Sullivan, Katherine C Nickels, Lieven Lagae, Renzo Guerrini, Sameer M Zuberi, Rima Nabbout, Kate Riney, Anupam Agarwal, Michael Lock, David Dai, Gail M Farfel, Bradley S Galer, Arnold R Gammaitoni, Shikha Polega, Ronald Davis, Antonio Gil-Nagel
Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study. Epilepsia (2022)
Renzo Guerrini, Nicola Specchio, Angel Aledo-Serrano, Milka Pringsheim, Francesca Darra, Thomas Mayer, Antonio Gil-Nagel, Tilman Polster, Sameer M Zuberi, Amélie Lothe, Arnold R Gammaitoni, Adam Strzelczyk
An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a real-world practice setting: A report from the Fenfluramine European Early Access Program. Epilepsia open 7 (4) (2022)
Joseph Sullivan, Nicola Specchio, Orrin Devinsky, Stėphane Auvin, Michael Scott Perry, Adam Strzelczyk, Antonio Gil-Nagel, David Dai, Bradley S Galer, Arnold R Gammaitoni
Fenfluramine significantly reduces day-to-day seizure burden by increasing number of seizure-free days and time between seizures in patients with Dravet syndrome: A time-to-event analysis. Epilepsia (2021)
Joseph Sullivan, Ingrid E Scheffer, Lieven Lagae, Rima Nabbout, Milka Pringsheim, Dinesh Talwar, Tilman Polster, Bradley S Galer, Michael Lock, Anupam Agarwal, Arnold R Gammaitoni, Glenn Morrison, Gail Farfel
Fenfluramine HCl (Fintepla® ) provides long-term clinically meaningful reduction in seizure frequency: Analysis of an ongoing open-label extension study. Epilepsia 61 (11) (2020)

Arnold R Gammaitoni.css-eqlu8i{font-size:small;padding-left:4px;} (Arnold Gammaitoni)

Publication Activity (10 Years)

Top Topics

Top Venues

Arnold R Gammaitoni (Arnold Gammaitoni)